Ted Treves News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ted Treves. Real-time updates on events, politics, business and more.

NephroScan Approved to Detect Renal Parenchymal Disorders

March 11, 2022

NephroScan (kit for the preparation of technetium Tc 99m succimer injection) aids in the scintigraphic evaluation of renal parenchymal disorders.

United States Ted Treves Theragnostics Inc Professor Of Radiology At Harvard Medical School Drug Administration Society Of Nuclear Medicine

Source: renalandurologynews.com

NephroScan Approved to Detect Renal Parenchymal Disorders

February 24, 2022

NephroScan (kit for the preparation of technetium Tc 99m succimer injection) aids in the scintigraphic evaluation of renal parenchymal disorders.

United States Ted Treves Professor Of Radiology At Harvard Medical School Drug Administration Society Of Nuclear Medicine Harvard Medical School

Source: empr.com

Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScan™ (Kit for the Preparation of Technetium Tc 99m Succimer Injection)

February 23, 2022

/PRNewswire/ -- Theragnostics announces that NephroScan, its radiodiagnostic imaging drug used as an aid for the evaluation of renal parenchymal disorders in...

United States City Of United Kingdom Pharmaka Gmb Ted Treves Greg Mullen

Source: prnewswire.com

Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScan™ (Kit for the Preparation of Technetium Tc 99m Succimer Injection)

February 23, 2022

/PRNewswire/ -- Theragnostics announces that NephroScan, its radiodiagnostic imaging drug used as an aid for the evaluation of renal parenchymal disorders in...

United States City Of United Kingdom Pharmaka Gmb Ted Treves Greg Mullen

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Ted Treves News Today

NephroScan Approved to Detect Renal Parenchymal Disorders

NephroScan Approved to Detect Renal Parenchymal Disorders

Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScan&#x2122; (Kit for the Preparation of Technetium Tc 99m Succimer Injection)

Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScan&#x2122; (Kit for the Preparation of Technetium Tc 99m Succimer Injection)

Explore More Categories

Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScan™ (Kit for the Preparation of Technetium Tc 99m Succimer Injection)

Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScan™ (Kit for the Preparation of Technetium Tc 99m Succimer Injection)